Pulmonary Vascular and Ventricular Dysfunction in the Susceptible Patient (2015 Grover Conference Series)
Open Access
- 1 December 2016
- journal article
- review article
- Published by Wiley in Pulmonary Circulation
- Vol. 6 (4) , 426-438
Abstract
Pulmonary blood vessel structure and tone are maintained by a complex interplay between endogenous vasoactive factors and oxygen-sensing intermediaries. Under physiological conditions, these signaling networks function as an adaptive interface between the pulmonary circulation and environmental or acquired perturbations to preserve oxygenation and maintain systemic delivery of oxygen-rich hemoglobin. Chronic exposure to hypoxia, however, triggers a range of pathogenetic mechanisms that include hypoxia-inducible factor 1α (HIF-1α)–dependent upregulation of the vasoconstrictor peptide endothelin 1 in pulmonary endothelial cells. In pulmonary arterial smooth muscle cells, chronic hypoxia induces HIF-1α-mediated upregulation of canonical transient receptor potential proteins, as well as increased Rho kinase-Ca2+ signaling and pulmonary arteriole synthesis of the profibrotic hormone aldosterone. Collectively, these mechanisms contribute to a contractile or hypertrophic pulmonary vascular phenotype. Genetically inherited disorders in hemoglobin structure are also an important etiology of abnormal pulmonary vasoreactivity. In sickle cell anemia, for example, consumption of the vasodilator and antimitogenic molecule nitric oxide by cell-free hemoglobin is an important mechanism underpinning pulmonary hypertension. Contemporary genomic and transcriptomic analytic methods have also allowed for the discovery of novel risk factors relevant to sickle cell disease, including GALNT13 gene variants. In this report, we review cutting-edge observations characterizing these and other pathobiological mechanisms that contribute to pulmonary vascular and right ventricular vulnerability.Keywords
Funding Information
- National Institutes of Health (HL126514, HL73859, R01HL127342, R01HL111656)
- American Heart Association (AHA 15GRNT2508 0016)
- Pulmonary Hypertension Association
This publication has 178 references indexed in Scilit:
- Pulmonary Arterial Enlargement and Acute Exacerbations of COPDNew England Journal of Medicine, 2012
- Mortality in Adults With Sickle Cell Disease and Pulmonary HypertensionJAMA, 2012
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- Digoxin inhibits development of hypoxic pulmonary hypertension in miceProceedings of the National Academy of Sciences, 2012
- Genetic Evidence for High-Altitude Adaptation in TibetScience, 2010
- Natural selection on EPAS1 ( HIF2α ) associated with low hemoglobin concentration in Tibetan highlandersProceedings of the National Academy of Sciences, 2010
- JNK signaling in apoptosisOncogene, 2008
- Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertensionBritish Journal of Pharmacology, 2008
- Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implicationsBritish Journal of Pharmacology, 2008
- The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targetedProceedings of the National Academy of Sciences, 2007